Drug profile · INN
iohexol
OMNIPAQUE 140
iohexol (OMNIPAQUE 140) is a diagnostic agent. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Drug details — iohexol
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 11
- Data quality
- 0.89
Quick answer
iohexol (OMNIPAQUE 140) is a diagnostic agent. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Diagnostic agent
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Frequently asked questions
What is iohexol?
iohexol (OMNIPAQUE 140) is a diagnostic agent. Associated with Amneal Pharma Europe Ltd. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for iohexol?
OMNIPAQUE 140 is a marketed brand name for iohexol. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of iohexol?
iohexol has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.